Michael Pollastri Professor and Interim Dean, College of Science m.pollastri@neu.edu 617.373.2703 Expertise chemical technology, green chemistry, medicinal chemistry Michael Pollastri in the Press Article How Disease Detectives Unearthed A Forgotten Drug To Fight A Lethal Illness Fexinidazole “is an excellent example of drug discovery scientists ‘rescuing’ a compound that was otherwise in the dustbin of a large drug company,” said Michael Pollastri, an associate processor in medicinal chemistry at Northeastern University who wasn’t involved with this research, in an earlier interview with HuffPost. “It’s a perfect example of how valuable it can be to […] Article A killer disease might be nearing the end of its deadly run “This drug seems likely to be approved for sleeping sickness, and is an excellent example of drug discovery scientists ‘rescuing’ a compound that was otherwise in the dustbin of a large drug company,” Michael Pollastri, an associate professor at Northeastern University, told HuffPost. Article What would happen if someone got Ebola in America? Let’s get one thing straight: You are not going to get Ebola. Donald Trump is not going to get Ebola. You are more likely to be killed by Batman, the ride. Ebola-like viruses have already breached our borders, and there were no secondary infections. There are airport workers whose job it is to identify passengers […] Article Nova Next What drug researchers can learn from a Kenyan clinic When I arrived at the remote clinic some 180 miles from Nairobi, it was near mid-day, and the Kenyan sun had pushed the thermometer to uncomfortable heights. Small insects buzzed in and out of the open windows of the low building—the only thing keeping them from landing on the patients were the insect nets draped […] Michael Pollastri for Northeastern Global News This tropical disease is second only to malaria as a parasitic killer. So why haven’t you heard of it? This tropical disease is second only to malaria as a parasitic killer. So why haven’t you heard of it? The deadly strain of leishmaniasis infects 300,000 people annually, causing 20,000 deaths. It's the second largest cause of parasitic death. Why you should care about rare tropical diseases Why you should care about rare tropical diseases They’re neglected, they’re tropical, and they affect mostly the poor—so why should Americans be concerned about tropical diseases? The science behind fireworks The science behind fireworks Collaboration: ‘Where the magic starts happening’ Collaboration: ‘Where the magic starts happening’ Northeastern’s research partnerships in Cuba open the doors to scientific exchange Northeastern’s research partnerships in Cuba open the doors to scientific exchange 3Qs: Four new elements added to periodic table 3Qs: Four new elements added to periodic table Graduate researcher wins fellowship to design drugs to combat deadly disease Graduate researcher wins fellowship to design drugs to combat deadly disease New grant to advance sleeping sickness treatment research New grant to advance sleeping sickness treatment research Through this $2.5 million award, Pollastri’s Laboratory will develop and test compounds identified as options for treating sleeping sickness. New research offers hope in treating sleeping sickness New research offers hope in treating sleeping sickness Neglected for too long Neglected for too long
Article How Disease Detectives Unearthed A Forgotten Drug To Fight A Lethal Illness Fexinidazole “is an excellent example of drug discovery scientists ‘rescuing’ a compound that was otherwise in the dustbin of a large drug company,” said Michael Pollastri, an associate processor in medicinal chemistry at Northeastern University who wasn’t involved with this research, in an earlier interview with HuffPost. “It’s a perfect example of how valuable it can be to […]
Article A killer disease might be nearing the end of its deadly run “This drug seems likely to be approved for sleeping sickness, and is an excellent example of drug discovery scientists ‘rescuing’ a compound that was otherwise in the dustbin of a large drug company,” Michael Pollastri, an associate professor at Northeastern University, told HuffPost.
Article What would happen if someone got Ebola in America? Let’s get one thing straight: You are not going to get Ebola. Donald Trump is not going to get Ebola. You are more likely to be killed by Batman, the ride. Ebola-like viruses have already breached our borders, and there were no secondary infections. There are airport workers whose job it is to identify passengers […]
Article Nova Next What drug researchers can learn from a Kenyan clinic When I arrived at the remote clinic some 180 miles from Nairobi, it was near mid-day, and the Kenyan sun had pushed the thermometer to uncomfortable heights. Small insects buzzed in and out of the open windows of the low building—the only thing keeping them from landing on the patients were the insect nets draped […]